A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

Por um escritor misterioso

Descrição

medRxiv - The Preprint Server for Health Sciences
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomes, Free Full-Text
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Frontiers Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study - eClinicalMedicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Immune response in COVID-19: what is next?
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice - eBioMedicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Metabolomics study of COVID-19 patients in four different clinical stages
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
de por adulto (o preço varia de acordo com o tamanho do grupo)